Insider filing report for Changes in Beneficial Ownership
- Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
- Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
|
United Health Products, Inc. (Name of Issuer) |
Common Stock (Title of Class of Securities) |
91059D100 (CUSIP Number) |
Suzanna Kolb 5600 Spalding Drive, Unit 920085 Norcross, GA, 30010-0085 760-609-9146 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
12/17/2024 (Date of Event Which Requires Filing of This Statement) |
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other
provisions of the Act (however, see the Notes).
SCHEDULE 13D
|
| CUSIP No. | 91059D100 |
| 1 |
Name of reporting person
Wendy Beplate Irrevocable Trust | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b)
| ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
OO | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UTAH
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
18,000,000.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
 | ||||||||
| 13 | Percent of class represented by amount in Row (11)
7.2 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN |
SCHEDULE 13D
|
| Item 1. | Security and Issuer |
| (a) | Title of Class of Securities:
Common Stock |
| (b) | Name of Issuer:
United Health Products, Inc. |
| (c) | Address of Issuer's Principal Executive Offices:
520 Fellowship Road, Suite #D-406, Mt. Laurel,
NEW JERSEY
, 08054. |
| Item 2. | Identity and Background |
| (a) | Wendy Beplate Irrevocable Trust-Suzanna Kolb, Special Independent Trustee |
| (b) | 5600 Spalding Drive, Unit 920085, Norcross GA 30010-0085 |
| (c) | N/A |
| (d) | N/A |
| (e) | N/A |
| (f) | N/A |
| Item 3. | Source and Amount of Funds or Other Consideration |
Douglas Beplate was the grantor in 2022 of the Reporting Person which is an irrevocable trust formed in Utah with Suzanna Kolb as its Special Independent Trustee. Mr. Beplate received the common stock for services rendered and then gifted the 18 million shares to the trust. | |
| Item 4. | Purpose of Transaction |
The Reporting Person does not have any present plans or proposals that relate to or would result in any of the actions required to be described in Item 4 of Schedule 13D. | |
| Item 5. | Interest in Securities of the Issuer |
| (a) | As of December 18, 2024, the reporting person beneficially owns 18 million shares of common stock of the issuer, representing 7.2% of the issuer's outstanding shares of common stock. The reporting person has the sole power to dispose of and vote the 18 million shares of Common Stock owned by him. The Reporting Person is an Irrevocable Grantor Trust that Douglas Beplate formed in 2022 and which the Issuer's common stock is managed by a Special Independent Trustee, namely Suzanna Kolb where the Reporting Person by the Trust terms cannot make Douglas Beplate (who individually owns 6.7 million shares), a beneficiary. The Reporting Person therefore disclaims any beneficial ownership of Mr. Beplate's individual shares. Also excludes 12,307 shares of common stock owned by his spouse, Wendy Beplate, who is a trustee of the Irrevocable Grantor Trust except for acting with respect to the Issuer's common stock. The Irrevocable Grantor Trust disclaims beneficial ownership and control of Common stock of the Issuer held by Wendy Beplate. |
| (b) | Incorporated by reference is item 5(a) above for the information required herein. |
| (c) | N/A |
| (d) | N/A |
| (e) | N/A |
| Item 6. | Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer |
N/A | |
| Item 7. | Material to be Filed as Exhibits. |
N/A |
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|